Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.

作者信息

Conzett Katrin Baumann, Kolm Isabel, Jelcic Ilijas, Kamarachev Jivko, Dummer Reinhard, Braun Ralph, French Lars E, Linnebank Michael, Hofbauer Günther F L

出版信息

Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212.

DOI:10.1001/archdermatol.2011.212

PMID:21844470

Abstract

摘要

相似文献

Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.

Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212.

Fingolimod for multiple sclerosis.

N Engl J Med. 2012 Jan 26;366(4):339-47. doi: 10.1056/NEJMct1101691.

Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.

J Neuroophthalmol. 2011 Sep;31(3):292-3. doi: 10.1097/WNO.0b013e31822bed20.

Oral fingolimod (gilenya) for multiple sclerosis.

Med Lett Drugs Ther. 2010 Dec 29;52(1353-1354):98-9.

Fingolimod: cardiovascular deaths.

Prescrire Int. 2012 Apr;21(126):99.

Delayed fingolimod-associated asystole.

Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7.

Cystoid macular edema associated with fingolimod use for multiple sclerosis.

JAMA Ophthalmol. 2013 Jan;131(1):103-7. doi: 10.1001/jamaophthalmol.2013.570.

Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.

Mult Scler. 2013 Oct;19(11):1551-2. doi: 10.1177/1352458513493035. Epub 2013 Jul 1.

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.

Neurology. 2012 Nov 6;79(19):2006-7. doi: 10.1212/WNL.0b013e3182735d24. Epub 2012 Oct 3.

[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].

Ideggyogy Sz. 2012 Nov 30;65(11-12):421-2.

引用本文的文献

Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.

Mult Scler J Exp Transl Clin. 2025 Aug 21;11(3):20552173251369990. doi: 10.1177/20552173251369990. eCollection 2025 Jul-Sep.

Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol.

BMJ Open. 2025 Jan 23;15(1):e088924. doi: 10.1136/bmjopen-2024-088924.

Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies.

Front Neuroinform. 2023 May 3;17:1154916. doi: 10.3389/fninf.2023.1154916. eCollection 2023.

Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review.

J Cent Nerv Syst Dis. 2021 Sep 2;13:11795735211037785. doi: 10.1177/11795735211037785. eCollection 2021.

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases.

J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211033047. doi: 10.1177/23247096211033047.

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article.

Biomedicines. 2020 Jul 18;8(7):227. doi: 10.3390/biomedicines8070227.

Multiple Sclerosis Treatment and Melanoma Development.

Int J Mol Sci. 2020 Apr 22;21(8):2950. doi: 10.3390/ijms21082950.

Detection of a new melanoma in a patient treated with fingolimod.

BMJ Case Rep. 2019 Apr 29;12(4):e227951. doi: 10.1136/bcr-2018-227951.

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients.

Ther Clin Risk Manag. 2018 Sep 26;14:1765-1788. doi: 10.2147/TCRM.S174864. eCollection 2018.

The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.

Oncogene. 2017 Jun 29;36(26):3760-3771. doi: 10.1038/onc.2017.2. Epub 2017 Feb 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验